PUBLISHER: Grand View Research | PRODUCT CODE: 1842052
PUBLISHER: Grand View Research | PRODUCT CODE: 1842052
The global fertility test market size was estimated at USD 7.38 billion in 2024 and is projected to reach USD 14.74 billion in 2033, growing at a CAGR of 8.08% from 2025 to 2033. This growth is attributed to lifestyle changes, higher stress levels, delayed pregnancies, and exposure to environmental pollutants.
In addition, there is a growing awareness of reproductive health and greater acceptance of fertility testing among both men and women, which encourages early diagnosis and intervention. Moreover, the rising prevalence of reproductive disorders, such as polycystic ovary syndrome (PCOS) and endometriosis, is encouraging more individuals to seek evaluations.
The increasing rates of infertility among both men and women are a significant factor driving the growth of the market. As per the report published by the World Health Organization (WHO) in April 2023, infertility affects approximately 1 in 6 adults, or 17.5% of the population. The report indicates that infertility rates are consistent across various regions and income levels, with a lifetime prevalence of 17.8% in high-income countries and 16.5% in low- and middle-income countries. This suggests that infertility is not confined to specific demographics or areas, making it a serious challenge for people worldwide.
Global Fertility Test Market Report Segmentation
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global fertility test market report based on test type, application, sample type, end-use, and region: